Evidence map›Paper›PMID 42510705›Full record

ArticleBiology2026

Age-Specific Transcriptomic Signatures for Classification of Progression-Free Survival Outcomes in Luminal A Breast Cancer: An Integrative Machine Learning Approach.

Mehmet Kivrak, Ihsan Nalkiran, Hatice Sevim Nalkiran

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mehmet KivrakDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Recep Tayyip Erdogan University, 53020 Rize, Türkiye.ORCID 0000-0002-2405-8552
Ihsan NalkiranDepartment of Medical Biology, Faculty of Medicine, Recep Tayyip Erdogan University, 53020 Rize, Türkiye.ORCID 0000-0002-7246-2592
Hatice Sevim NalkiranDepartment of Medical Biology, Faculty of Medicine, Recep Tayyip Erdogan University, 53020 Rize, Türkiye.ORCID 0000-0002-1115-2005

Funding

Recep Tayyip Erdoğan University 020260070010446
6 · The paper itself

Abstract

Progression-free survival (PFS) is an important clinical endpoint in Luminal A breast cancer (BC), yet the molecular determinants of recurrence remain incompletely understood. This study aimed to identify recurrence-associated transcriptomic alterations across age-defined patient subgroups and evaluate their predictive utility using machine learning (ML). Gene expression profiles and clinical data from the METABRIC cohort were analyzed in premenopausal, postmenopausal non-geriatric, and geriatric patients with Luminal A BC. Differential expression analysis identified 32 significantly dysregulated genes, of which 15 genes with |log

Indexed as

Luminal A breast cancermachine learningprogression-free survivalrecurrencetranscriptomic signatures

Identifiers

PMID42510705
PMCPMC13405475

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.